Some of the names on the move ahead of the open.» Read More
The U.S. Food and Drug Administration warned that popular acne products can cause rare but serious and life-threatening allergic reactions.
WASHINGTON, June 23- President Barack Obama met with Goldman Sachs Chief Executive Lloyd Blankfein, Johnson& Johnson chief Alex Gorsky and other business leaders on Monday to discuss ways to encourage companies to make their work places more family friendly.
WASHINGTON, June 23- President Barack Obama on Monday directed the federal government to give workers more leeway in determining their schedules, part of his goal to make U.S. workplaces more family-friendly- and a broad pitch to Democratic voters ahead of November elections.
The US population is getting grayer, and while getting old stinks, there are plenty of ways to profit from an aging demographic using ETFs.
SAN FRANCISCO, June 23- For decades, medical technology firms have searched for ways to let diabetics check blood sugar easily, with scant success.
*European Commission declines to comment. BRUSSELS, June 19- EU antitrust regulators are set to fine French drugmaker Servier, Israel's Teva and several of their peers next month for blocking cheaper generic medicine, two people with knowledge of the matter said on Thursday.
The new UK Dementias Research Platform will investigate the causes of dementia by tracking volunteers, aged 50 and over, who are taking part in existing population studies such as UK Biobank and the Million Women Study. Major pharmaceutical companies backing the initiative include AstraZeneca, GlaxoSmithKline and Johnson& Johnson.
The Dow and S&P 500 gained in at least 12 World Cups, on average more than 5 percent for the year.
June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.
Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.
Medtronic is buying Covidien in a $42.9 billion agreement that could increase concerns about the rush of U.S. companies striking deals to cut their tax bills.
SHANGHAI, June 13- China's crackdown on corruption in the pharmaceutical sector has frightened foreign executives so much that some fear they could be jailed and have asked their lawyers if they should leave the country for six months.
Some of the names on the move ahead of the open.
In the past three years, the category of low-volatility ETFs has mushroomed, but whether they work or not remains an open question.
LONDON, June 12- Johnson& Johnson has linked up with ViiV Healthcare- a specialist HIV company majority-owned by GlaxoSmithKline- to develop a new AIDS medicine combining two drugs in a single tablet.
Achillion's been a takeover target for years. But Merck's acquisition of Idenix may mean Achillion's time has come.
A takeover bid that caused much consternation didn't even go through after AstraZeneca PLC said "no thanks" to Pfizer Inc. in April. The episode caused Eric Sappenfield, co-manager of the John Hancock Global Shareholder Yield Fund, to turn cautious on Pfizer, although he still owns some.
June 10- Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration allowed it to resume the development of one of its hepatitis C drugs, lifting a clinical hold that was imposed nearly a year ago.
Analysts say there's more to Merck's interest in Idenix than its drug portfolio: intellectual property. And that's why Gilead's shares are lower.
June 6- An infectious disease expert and former head dealmaker at Merck& Co is racing against his ex-employer and other drugmakers to develop a treatment for a germ that ravages the colon and kills as many as 14,000 Americans each year.